Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer

Oncology

Volumn 56, Issue 3, 1999, Pages 177-180

  Raderer, Markus ^a   Hejna, M H L ^b   Valencak, J B ^b   Kornek, G V ^b   Weinlander G S ^b   Bareck, E ^b   Lenauer, J ^b   Brodowicz, T ^b   Lang, F ^b   Scheithauer, W ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

5 FU; Biliary cancer; Gemcitabine; Leucovorin; Mitomycin C

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C;

ADVANCED CANCER; ANEMIA; ARTICLE; BILE DUCT CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEVER; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

EID: 0032907615     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011961     Document Type: Article

References (15)

1. Pitt HA, Dooley WC, Cameron JL: Malignancies of the biliary tree. Curr Probl Surg 1995; 32:1.
2. Klempnauer J, Ridder GJ, von Wasiliewski R, et al: Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors. J Clin Oncol 1997;15:947-954.
3. Blumgart LH, Stain SC: Surgical treatment of cholangiocarcinoma: in Sugarbaker PH (ed): Hepatobiliary Cancer. Boston, Kluwer Academic, 1994, pp 75-96.
4. Altaee MY, Johnson PJ, Farrant JM. et al: Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991; 68:2051-2055.
5. Klapdor R: Perspectives in chemotherapy of pancreatic cancer. Eur J Surg Oncol 1991;17: 153-166.
6. Glimelius B, Hoffmann K, Sjöden PO, et al: Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.
7. Hejna MHL, Pruckmayer M, Raderer M: The role of chemotherapy and radiation in the treatment of biliary cancer: A review of the literature. Eur J Cancer 1998;34:977-986.
8. Taal BG, Audisio RA, Bleiberg H, et al: Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma: An EORTC gastrointestinal tract cancer cooperative roup. Ann Oncol 1991;4:607-612.
9. Falkson G, MacIntyre JM, Moertel CG: Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bileduct cancer. Cancer 1984;54:965-969.
10. Ravry MJR, Omura GA, Bartolucci AA, et al: Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: A Southern Cancer Study Group trial. Cancer Treat Rep 1986;70:311-317.
11. Patt YZ, Jones DV Jr, Hoque A, et al: Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer. J Clin Oncol 1996;14:2311-2315.
12. Csoka K, Lilienmark J, Larsson R, Nygren P: Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Semin Oncol 1995;22:47-53.
13. Burris HA, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997;15:2403-2413.
14. Hehenwarter W, Wein W, Schneider G, et al: Gemcitabine in cholangiocarcinoma: Initially inoperable patient currently disease free (case report). 21st Euro Soc Medical Oncology Congr, Vienna, Proc, abstr 246P, 1996.
15. Mezger J, Sauerbruch T, Ko Y, et al: Phase II trial of gemcitabine in biliary tract cancer. Proc Am Soc Clin Oncol, 1997, abstr 1059.